OKLAHOMA CITY (AP) — Cason Wallace got the call to start Game 1 of the NBA Finals for the Oklahoma City Thunder on Thursday night, taking the place of Isaiah Hartenstein.
The Thunder had used the same starting five — Shai Gilgeous-Alexander, Lu Dort, Jalen Williams, Chet Holmgren and Hartenstein — for each of the 16 games needed to get through the Western Conference playoffs.
At 21 years and seven months, Wallace is the youngest player to start an NBA Finals game since Miami’s Tyler Herro — then about 20 years and 9 months — started for the Heat in their series inside the bubble against the Los Angeles Lakers in 2020.
Wallace started 43 games in the regular season for the Thunder. He had appeared in 26 playoff games over his first two NBA seasons with Oklahoma City, but Thursday's series opener against the Indiana Pacers was his first playoff start.
Wallace averaged 8.4 points in the regular season and has averaged 5.4 in the playoffs coming into the finals.
AP NBA: https://apnews.com/hub/NBA
Oklahoma City Thunder guard Cason Wallace (22) drives to the basket against Minnesota Timberwolves center Naz Reid during the second half of Game 4 of the Western Conference finals of the NBA basketball playoffs Monday, May 26, 2025, in Minneapolis. (AP Photo/Matt Krohn)
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Jan 12, 2026--
ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To support its growth in the region, ChemWerth has hired Chandrakanth Reddy as general sales manager of its India office.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260111302280/en/
“The addition of a general sales manager in India signals our desire to grow our presence and customer base in the world’s most important generic pharmaceutical market,” said Pete Werth III, president, ChemWerth. “Chandrakanth will add tremendous value for our customers and contract manufacturing organizations (CMOs) in India.”
Reddy is a seasoned pharmaceutical professional with more than 16 years of experience spanning API sourcing, business development, market expansion and regulatory-driven commercial strategy. He has successfully led high-value markets across India, the Middle East, North Africa, Europe, and the United States, building strong customer partnerships and supporting sustainable revenue growth.
In his new role, Reddy will be responsible for leading ChemWerth’s sales strategy in India and strengthening regional customer relationships. He will also support the company’s focused initiative to roll out new generic APIs in the market, including fermentation, peptide and oncology injectable APIs.
“After reviewing ChemWerth’s strategic plan to unveil a strong pipeline of new generic fermentation, peptide and oncology injectable APIs for the Indian market, I knew that was something I wanted to be a part of,” said Reddy.
About ChemWerth, Inc.:
Established in 1982, ChemWerth is a full-service generic active pharmaceutical ingredient (API) development and supply company providing cGMP-quality APIs to regulated markets worldwide. ChemWerth is a global company headquartered in the United States, with offices in China and India. For more information, please visit www.chemwerth.com.
Chandrakanth Reddy has joined ChemWerth, Inc., as general sales manager of its India office.
